AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9527193
Drug: High-dose epsilon-aminocaproic
RxNorm normalized name: Epsilon Aminocaproic Acid
DrugBank: Aminocaproic acid (DB00513)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High-dose epsilon-aminocaproic acid (10 g loading and priming dose, 2.5 g/h until 4 hours after protamine)
Trial: 7993957
Drug: BRL 46470
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BRL 46470 (1 mg orally)
Trial: 7814826
Drug: mCPP (0.08
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mCPP (0.08 mg/kg over 2 min)
Trial: 30099
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg diazepam, t.i.d.
Trial: 30099
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg chlordiazepoxide, t.i.d.
Trial: 30099
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment perception
Trial: 24609887
Drug: IL-1ra (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IL-1ra (100 mg for 4 weeks)
Trial: 20164847
Drug: Amlodipine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (10 mg/day) + Olmesartan medoxomil (40 mg/day)
Trial: 20164847
Drug: Olmesartan medoxomil
RxNorm normalized name: Olmesartan Medoxomil
DrugBank: Olmesartan (DB00275)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olmesartan medoxomil (40 mg/day)
Trial: 18058482
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation of thioctic acid (ALA) 600 mg
Trial: 18058482
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation of thioctic acid
Trial: 16075942
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (water treatment device with filter and UV light)
Trial: 16075942
Drug: Sham treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham treatment (no treatment device)
Trial: 12126819
Drug: High-intensity oral
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-intensity oral anticoagulation
Trial: 12126819
Drug: Combined low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Combined low-dose aspirin and moderate intensity oral anticoagulation
Trial: 8712395
Drug: 10 micrograms/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 micrograms/kg intravenous (IV) bolus alfentanil
Trial: 8712395
Drug: 20 micrograms/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 micrograms/kg intravenous (IV) bolus alfentanil
Trial: 1789687
Drug: Octreotide (synthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octreotide (synthetic analogue of somatostatin) administered intravenously under double-blind, placebo-controlled conditions.
Trial: 1789687
Drug: Octreotide infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octreotide infusion in 6 patients.
Trial: 31286476
Drug: Spinal sufentanil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal sufentanil (5 µg)
Trial: 31286476
Drug: Epidural sufentanil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural sufentanil (20 µg)
Trial: 31286476
Drug: Spinal fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Spinal fentanyl (20 µg)
Trial: 31286476
Drug: Epidural fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Epidural fentanyl (100 µg)
Trial: 15951574
Drug: Dietary advice,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary advice, blood glucose monitoring, and insulin therapy as needed
Trial: 7738618
Drug: Hormone therapy
RxNorm normalized name: INVESTIGATIONAL HORMONE THERAPY/REPLACEMENT,OTHER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hormone therapy with megestrol acetate
Trial: 11896093
Drug: Hormone therapy
RxNorm normalized name: INVESTIGATIONAL HORMONE THERAPY/REPLACEMENT,OTHER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hormone therapy with an aromatase inhibitor (fadrozole or letrozole)
Trial: 11896093
Drug: Hormone therapy
RxNorm normalized name: INVESTIGATIONAL HORMONE THERAPY/REPLACEMENT,OTHER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hormone therapy (combined response to both interventions)
Trial: 9707853
Drug: Dexamethasone 0.5
RxNorm normalized name: dexamethasone 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 0.5 mg/kg/dose 12 hourly for 3 days starting within 6 hours of birth
Trial: 7241356
Drug: Tablet (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet (50 mg propiram fumarate)
Trial: 7241356
Drug: Solution (50
RxNorm normalized name: salicylic acid 1 % Topical Solution (50 mL) / salicylic acid 1.5 % Topical Gel (30 mL) / salicylic acid 2 % Medicated Liquid Soap (50 mL) Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solution (50 mg propiram fumarate)
Trial: 7241356
Drug: Tablet and
RxNorm normalized name: TABLET AND CAPSULE, DOSE PACK
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet and Solution (comparison)
Trial: 21498125
Drug: Dalteparin sodium
RxNorm normalized name: Dalteparin Sodium
DrugBank: Dalteparin (DB06779)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalteparin sodium 2500 IU s.c. daily, in addition to routine luteal phase support
Trial: 7596934
Drug: Captopril (12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (12.5 mg bid)
Trial: 8934214
Drug: Enalapril (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (2.5 mg bid)
Trial: 619842
Drug: Therapy plus
RxNorm normalized name: Lubriderm Advanced Therapy Plus Ceramide Lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapy plus drugs
Trial: 619842
Drug: Five different
RxNorm normalized name: HISTA-FIVE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Five different treatment methods
Trial: 12100441
Drug: CQ +
RxNorm normalized name: Chloroquine
DrugBank: Chloroquine (DB00608)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CQ + SP administered sequentially (CQ0 + SP4)
Trial: 12100441
Drug: CQ +
RxNorm normalized name: Chloroquine
DrugBank: Chloroquine (DB00608)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CQ + SP administered simultaneously (CQ0 + SP0)
Trial: 15687338
Drug: Hormone Replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone Replacement Therapy (HRT) - conjugated estrogens (0.625 mg) plus medroxyprogesterone acetate (2.5 mg)
Trial: 9915375
Drug: Right half-field
RxNorm normalized name: Field mushroom
DrugBank: Field mushroom (DB15605)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Right half-field patches (n = 7)
Trial: 9915375
Drug: Right monocular
RxNorm normalized name: Molecular AF
DrugBank: Tolnaftate (DB00525)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Right monocular patch (n = 7)
Trial: 2110338
Drug: Atropine 1.5
RxNorm normalized name: homatropine 1.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine 1.5 mg/70 kg, intramuscularly
Trial: 2110338
Drug: Atropine 3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine 3.0 mg/70 kg, intramuscularly
Trial: 2110338
Drug: Atropine 6.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine 6.0 mg/70 kg, intramuscularly
Trial: 543889
Drug: Ampicillin 3
RxNorm normalized name: ampicillin 389 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ampicillin 3 g + Oxacillin 2 g
Trial: 543889
Drug: Ampicillin 2
RxNorm normalized name: ampicillin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ampicillin 2 g + Oxacillin 1 g
Trial: 543889
Drug: Mezlocillin 3.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mezlocillin 3.75 g + Oxacillin 1.25 g
Trial: 543889
Drug: Mezlocillin 2
RxNorm normalized name: mezlocillin 250 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mezlocillin 2 g + Oxacillin 1 g
Trial: 543889
Drug: Carbenicillin 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbenicillin 7.5 g + Oxacillin 2.5 g
Trial: 543889
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of penicillins
Trial: 543889
Drug: Oxacillin 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxacillin 2.5 g + Carbenicillin 7.5 g
Trial: 30663401
Drug: Adaptive interventions
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adaptive interventions for engaging patients in treatment
Trial: 22563197
Drug: Reduced volume
RxNorm normalized name: Iron, reduced
DrugBank: Iron (DB01592)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reduced volume method (Group A) - did not drink PEG‐ELS the day before; drank 2 L on procedure day.
Trial: 22563197
Drug: Conventional volume
RxNorm normalized name: VOLUME EXPANDERS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional volume method (Group B) - drank 2 L PEG‐ELS the day before; drank 1 L on procedure day.
Trial: 20207721
Drug: Acetaminophen (APAP)
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (APAP) 15 mg/kg with 100% RDA for SAA
Trial: 20207721
Drug: Acetaminophen (APAP)
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (APAP) with 0% RDA for SAA
Trial: 17684986
Drug: Controlled epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled epidural analgesia (PCEA) with fentanyl, 2 microg/ml, in 0.2% bupivacaine solution (Group 1)
Trial: 17684986
Drug: Bolus infections
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus infections of fentanyl, 2 microg/ml, in 0.2% bupivacaine solution (Group 2)
Trial: 17684986
Drug: Continuous epidural
RxNorm normalized name: ACCU-BLOC PERIFIX CONTINUOUS EPIDURAL ANESTHESIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous epidural infusion of fentanyl, 2 microg/ml, in 0.2% bupivacaine solution (Group 3)
Trial: 9922856
Drug: Trinipatch (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trinipatch (5 mg/24 h and 10 mg/24 h)
Trial: 7804442
Drug: Intravenous dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous dexamethasone (4 mg for adults, 2 mg/m2 for children)
Trial: 7804442
Drug: Oral dexamethasone
RxNorm normalized name: dexamethasone Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral dexamethasone (8 mg for adults, 4 mg for children)
Trial: 3051324
Drug: Pancreatic glucagon
RxNorm normalized name: Glucagon
DrugBank: Glucagon (DB00040)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Pancreatic glucagon (G)
Trial: 3051324
Drug: 1-21 fragment
RxNorm normalized name: PALMITOYL FRAGMENT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-21 fragment of pancreatic glucagon (G 1-21)
Trial: 28357975
Drug: MicroExpression Training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MicroExpression Training Tool (METT), twice weekly for 4 weeks
Trial: 23850170
Drug: Treatment selection
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment selection based on biomarkers
Trial: 19567516
Drug: 1.25 mg
RxNorm normalized name: menthol 1.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.25 mg oral vitamin D(3) (n = 8)
Trial: 19567516
Drug: 1.25 mg
RxNorm normalized name: menthol 1.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.25 mg oral vitamin D(2) (n = 9)
Trial: 15365313
Drug: Energy drink
RxNorm normalized name: Boost Energy Drink
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Energy drink (3.57 ml/kg Red Bull)
Trial: 10931079
Drug: Testosterone undecanoate
RxNorm normalized name: Testosterone Undecanoate
DrugBank: Testosterone undecanoate (DB13946)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone undecanoate (1000 mg) + oral levonorgestrel (250 microg daily)
Trial: 10931079
Drug: Testosterone undecanoate
RxNorm normalized name: Testosterone Undecanoate
DrugBank: Testosterone undecanoate (DB13946)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone undecanoate (1000 mg) + oral placebo
Trial: 7876402
Drug: Nabumetone (NAB)
RxNorm normalized name: Nabumetone
DrugBank: Nabumetone (DB00461)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nabumetone (NAB) 1000 mg daily
Trial: 7876402
Drug: Indomethacin (IND)
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Indomethacin (IND) 50 mg every 12 hours
Trial: 7876402
Drug: Sulindac (SUL)
RxNorm normalized name: Sulindac
DrugBank: Sulindac (DB00605)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sulindac (SUL) 200 mg every 12 hours
Trial: 31770016
Drug: Scutellaria baicalensis
RxNorm normalized name: SCUTELLARIA BAICALENSIS
DrugBank: Scutellaria baicalensis root (DB14364)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scutellaria baicalensis (SB) 3.52 g/day
Trial: 23819242
Drug: Acupoint injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupoint injection with small dose of fentanyl-droperido mixed liquor
Trial: 23819242
Drug: Subcutaneous injection
RxNorm normalized name: EPINEPHRINE 0.3 mg SUBCUTANEOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous injection with fentanyl-droperido mixed liquor
Trial: 23819242
Drug: Subcutaneous injection
RxNorm normalized name: EPINEPHRINE 0.3 mg SUBCUTANEOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous injection of 0.9% NaCl
Trial: 21059094
Drug: Linagliptin 1
RxNorm normalized name: empagliflozin-linagliptin 10 mg-5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linagliptin 1 mg
Trial: 21059094
Drug: Glimepiride (1-3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glimepiride (1-3 mg)
Trial: 16996844
Drug: Enoxaparin (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin (1.5 mg/kg daily for 3 months)
Trial: 16996844
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (angiotensin-converting enzyme inhibitors, beta-blockers, diuretics)
Trial: 12000508
Drug: Clotrimazole 1%
RxNorm normalized name: CLOTRIMAZOLE 1% LOTION
DrugBank: Clotrimazole (DB00257)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clotrimazole 1% cream, once daily
Trial: 12000508
Drug: Ketoconazole 2%
RxNorm normalized name: KETOCONAZOLE 2% CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoconazole 2% cream, twice daily
Trial: 9509380
Drug: Yohimbine (5.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yohimbine (5.4 mg orally, 3 times daily, beginning at menses)
Trial: 2195890
Drug: Once-daily dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily dosing of netilmicin (2 g ceftriaxone also administered)
Trial: 2195890
Drug: Conventional multiple-daily-dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional multiple-daily-dosing regimen of netilmicin (2 g ceftriaxone also administered)
Trial: 8514653
Drug: Once-daily dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily dosing of netilmicin
Trial: 2195890
Drug: Conventional doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional doses of netilmicin
Trial: 2195890
Drug: Once-daily doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily doses of netilmicin
Trial: 2195890
Drug: Once-daily dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily dosing of netilmicin plus ceftriaxone
Trial: 3494725
Drug: Tinidazole (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tinidazole (2 g single dose)
Trial: 3494725
Drug: Metronidazole (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole (2 g single dose)
Trial: 6804724
Drug: EPSDT program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EPSDT program (early and periodic screening, diagnosis and treatment)
Trial: 21135795
Drug: Standardized local
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized local treatment combined with compression therapy
Trial: 17917828
Drug: Adjuvant 5‐fluorouracil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant 5‐fluorouracil (5FU) based chemotherapy
Trial: 17917828
Drug: Preoperative radiotherapy
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative radiotherapy in rectal cancer patients
Trial: 15501929
Drug: Urine Na+
RxNorm normalized name: Urin DS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urine Na+ and K+ excretion
Trial: 15501929
Drug: Antidiuretic hormone
RxNorm normalized name: Antidiuretic hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidiuretic hormone levels
Trial: 11899188
Drug: L-arginine-enriched solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine-enriched solution (7.5 g/500 mL)
Trial: 11899188
Drug: Standard blood
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard blood cardioplegic solution (Control)
Trial: 7621490
Drug: Topical applications
RxNorm normalized name: honey based topical applications
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical applications of amine fluoride solution (1%) - Group A (positive control)
Trial: 7621490
Drug: Topical applications
RxNorm normalized name: honey based topical applications
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical applications of amine fluoride solution (0.5% F) - Group B
Trial: 7621490
Drug: Topical applications
RxNorm normalized name: honey based topical applications
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical applications of amine fluoride solution (0.25% F) - Group C
Trial: 7196807
Drug: Cisplatin 30
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin 30 mg/m2
Trial: 2689396
Drug: Cisplatin (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin (all doses) with hyperthermia and radiation
Trial: 23458673
Drug: Anti-cocaine vaccine
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-cocaine vaccine
Trial: 21284801
Drug: TB-402 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TB-402 0.3 mg kg(‐1)
Trial: 21284801
Drug: TB-402 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TB-402 0.6 mg kg(‐1)
Trial: 21284801
Drug: TB-402 1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TB-402 1.2 mg kg(‐1)
Trial: 22215944
Drug: Spray
RxNorm normalized name: Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spray
Trial: 17341515
Drug: Self-administered electronic
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-administered electronic questionnaire
Trial: 17341515
Drug: Self-administered paper-and-pencil
RxNorm normalized name: paper birch pollen extract
DrugBank: Betula papyrifera pollen (DB10831)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-administered paper-and-pencil questionnaire
Trial: 17341515
Drug: Orally-administered interview
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orally-administered interview questionnaire
Trial: 12133040
Drug: eletriptan 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: eletriptan 80 mg
Trial: 9794981
Drug: Ibuprofen syrup
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen syrup (20 mg/mL, 0.25 mL per kg per dose, administered every 6 hours during fever)
Trial: 9794981
Drug: Placebo (matching
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (matching syrup, administered every 6 hours during fever)
Trial: 509345
Drug: Physostigmine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physostigmine administered immediately upon termination of anaesthesia
Trial: 509345
Drug: Physostigmine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physostigmine administered 30 minutes after the last dose of ketamine
Trial: 30009735
Drug: Qingfeihuayutongfu prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Qingfeihuayutongfu prescription (200 mL through nasal feeding, one dose per day for 7 days)
Trial: 30009735
Drug: Qingfeihuayutongfu prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Qingfeihuayutongfu prescription
Trial: 22626799
Drug: Transhiatal esophagectomy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transhiatal esophagectomy after chemotherapy
Trial: 22626799
Drug: Transhiatal esophagectomy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transhiatal esophagectomy without chemotherapy
Trial: 22626799
Drug: Transhiatal esophagectomy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transhiatal esophagectomy with chemotherapy
Trial: 11738765
Drug: Anthrax vaccine
RxNorm normalized name: ANTHRAX VACCINE
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anthrax vaccine (AVA)
Trial: 9430010
Drug: Erythromycin (EM)
RxNorm normalized name: Erythromycin
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Erythromycin (EM) 250 mg intravenously
Trial: 2896401
Drug: Standardized hemodilution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized hemodilution treatment (venesection and dextran 40 administration)
Trial: 2896401
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no hemodilution treatment)
Trial: 30098962
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion furosemide